Discoidin domain receptor 2 facilitates prostate cancer bone metastasis via regulating parathyroid hormone-related protein

Biochimica et Biophysica Acta - Molecular Basis of Disease

Volumn 1842, Issue 9, 2014, Pages 1350-1363

  Yan, Zhang ^a   Jin, Su ^b   Wei, Zhang ^b   Huilian, Hou ^a   Zhanhai, Yin ^a   Yue, Teng ^a   Juan, Li ^a   Jing, Li ^a   Libo, Yao ^b   Xu, Li ^a  

^a THE FIRST AFFILIATED HOSPITAL OF XI AN JIAOTONG UNIVERSITY   (China)

^b FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Bone metastasis; DDR2; Prostate cancer; PTHrP; Runx2

Indexed keywords

BETA ACTIN; COLLAGEN TYPE 1; DISCOIDIN DOMAIN RECEPTOR 2; FIBRONECTIN; MESSENGER RNA; OSTEOCLAST DIFFERENTIATION FACTOR; PARATHYROID HORMONE RELATED PROTEIN; PROTEIN TYROSINE KINASE; SHORT HAIRPIN RNA; TRANSCRIPTION FACTOR RUNX2; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BONE METASTASIS; CANCER CELL CULTURE; CELL DIFFERENTIATION; CELL PROLIFERATION; CONTROLLED STUDY; GEL MOBILITY SHIFT ASSAY; IMMUNOHISTOCHEMISTRY; LNCAP CELL LINE; MALE; MOUSE; NONHUMAN; OSTEOCLAST ACTIVITY; OSTEOCLASTOGENESIS; OSTEOLYSIS; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATE HYPERTROPHY; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR MICROENVIRONMENT; WESTERN BLOTTING;

BONE METASTASIS; DDR2; PROSTATE CANCER; PTHRP; RUNX2;

ANIMALS; BLOTTING, WESTERN; BONE NEOPLASMS; CELL ADHESION; CELL MOVEMENT; CELL PROLIFERATION; COLLAGEN TYPE I; ELECTROPHORETIC MOBILITY SHIFT ASSAY; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LUCIFERASES; MALE; MICE; OSTEOBLASTS; OSTEOCLASTS; PARATHYROID HORMONE-RELATED PROTEIN; PHOSPHORYLATION; PROMOTER REGIONS, GENETIC; PROSTATIC NEOPLASMS; REAL-TIME POLYMERASE CHAIN REACTION; RECEPTOR PROTEIN-TYROSINE KINASES; RECEPTORS, MITOGEN; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; TRANSFORMING GROWTH FACTOR BETA; TUMOR CELLS, CULTURED; WOUND HEALING;

EID: 84903539996     PISSN: 09254439     EISSN: 1879260X     Source Type: Journal    
DOI: 10.1016/j.bbadis.2014.04.018     Document Type: Article

References (45)

1. Jemal A., Bray F., Center M.M., Ferlay J., Ward E., Forman D. Global cancer statistics. CA Cancer J. Clin. 2011, 61(2):69-90.
2. Baade P.D., Youlden D.R., Krnjacki L.J. International epidemiology of prostate cancer: geographical distribution and secular trends. Mol. Nutr. Food Res. 2009, 53(2):171-184.
3. Jemal A., Siegel R., Ward E., Hao Y., Xu J., Murray T., Thun M.J. Cancer statistics. CA Cancer J. Clin. 2008, 58(2):71-96.
4. Lorch A. Metastatic prostate cancer: new insights and developments. Dtsch. Med. Wochenschr. 2013, 138(14):703-706.
5. Roodman G.D. Genes associate with abnormal bone cell activity in bone metastasis. Cancer Metastasis Rev. 2012, 31(3-4):569-578.
6. Casimiro S., Guise T.A., Chirgwin J. The critical role of the bone microenvironment in cancer metastases. Mol. Cell. Endocrinol. 2009, 310(1-2):71-81.
7. Yoneda T. Mechanism and strategy for treatment of cancer metastasis to bone. Gan To Kagaku Ryoho 2011, 38(6):877-884.
8. Juárez P., Guise T.A. TGF-β in cancer and bone: implications for treatment of bone metastases. Bone 2011, 48(1):23-29.
9. Buijs J.T., Juárez P., Guise T.A. Therapeutic strategies to target TGF-β in the treatment of bone metastases. Curr. Pharm. Biotechnol. 2011, 12(12):2121-2137.
10. Faccio R. Immune regulation of the tumor/bone vicious cycle. Ann. N. Y. Acad. Sci. 2011, 1237:71-78.
11. Soki F.N., Park S.I., McCauley L.K. The multifaceted actions of PTHrP in skeletal metastasis. Future Oncol. 2012, 8(7):803-817.
12. Isowa S., Shimo T., Ibaragi S., Kurio N., Okui T., Matsubara K., Hassan N.M., Kishimoto K., Sasaki A. PTHrP regulates angiogenesis and bone resorption via VEGF expression. Anticancer Res. 2010, 30(7):2755-2767.
13. Liao J., Li X., Koh A.J., Berry J.E., Thudi N., Rosol T.J., Pienta K.J., McCauley L.K. Tumor expressed PTHrP facilitates prostate cancer-induced osteoblastic lesions. Int. J. Cancer 2008, 123(10):2267-2278.
14. Mak I.W., Cowan R.W., Turcotte R.E., Singh G., Ghert M. PTHrP induces autocrine/paracrine proliferation of bone tumor cells through inhibition of apoptosis. PLoS One 2011, 6(5):e19975.
15. Kremer R., Li J., Camirand A., Karaplis A.C. Parathyroid hormone related protein (PTHrP) in tumor progression. Adv. Exp. Med. Biol. 2011, 720:145-160.
16. Rucci N., Teti A. Osteomimicry: how tumor cells try to deceive the bone. Front. Biosci. (Schol. Ed.) 2010, 2:907-915.
17. Pratap J., Lian J.B., Javed A., Barnes G.L., van Wijnen A.J., Stein J.L., Stein G.S. Regulatory roles of Runx2 in metastatic tumor and cancer cell interactions with bone. Cancer Metastasis Rev. 2006, 25(4):589-600.
18. Akech J., Wixted J.J., Bedard K., van der Deen M., Hussain S., Guise T.A., van Wijnen A.J., Stein J.L., Languino L.R., Altieri D.C., Pratap J., Keller E., Stein G.S., Lian J.B. Runx2 association with progression of prostate cancer in patients: mechanisms mediating bone osteolysis and osteoblastic metastatic lesions. Oncogene 2010, 29(6):811-821.
19. Pratap J., Lian J.B., Stein G.S. Metastatic bone disease: role of transcription factors and future targets. Bone 2011, 48(1):30-36.
20. Baniwal S.K., Khalid O., Gabet Y., Shah R.R., Purcell D.J., Mav D., Kohn-Gabet A.E., Shi Y., Coetzee G.A., Frenkel B. Runx2 transcriptome of prostate cancer cells: insights into invasiveness and bone metastasis. Mol. Cancer 2010, 9:258.
21. Pratap J., Wixted J.J., Gaur T., Zaidi S.K., Dobson J., Gokul K.D., Hussain S., van Wijnen A.J., Stein J.L., Stein G.S., Lian J.B. Runx2 transcriptional activation of Indian Hedgehog and a downstream bone metastatic pathway in breast cancer cells. Cancer Res. 2008, 68(19):7795-7802.
22. Javed A., Barnes G.L., Pratap J., Antkowiak T., Gerstenfeld L.C., van Wijnen A.J., Stein J.L., Lian J.B., Stein G.S. Impaired intranuclear trafficking of Runx2 (AML3/CBFA1) transcription factors in breast cancer cells inhibits osteolysis in vivo. Proc. Natl. Acad. Sci. U. S. A. 2005, 102(5):1454-1459.
23. Shrivastava A., Radziejewski C., Campbell E., Kovac L., McGlynn M., Ryan T.E., Davis S., Goldfarb M.P., Glass D.J., Lemke G., Yancopoulos G.D. An orphan receptor tyrosine kinase family whose members serve as nonintegrin collagen receptors. Mol. Cell 1997, 1(1):25-34.
24. Vogel W., Gish G.D., Alves F., Pawson T. The discoidin domain receptor tyrosine kinases are activated by collagen. Mol. Cell 1997, 1(1):13-23.
25. Vonk L.A., Doulabi B.Z., Huang C., Helder M.N., Everts V., Bank R.A. Collagen-induced expression of collagenase-3 by primary chondrocytes is mediated by integrin α1 and discoidin domain receptor 2: a protein kinase C-dependent pathway. Rheumatology (Oxford) 2011, 50(3):463-472.
26. Sivakumar L., Agarwal G. The influence of discoidin domain receptor 2 on the persistence length of collagen type I fibers. Biomaterials 2010, 31(18):4802-4808.
27. Su J., Yu J., Ren T., Zhang W., Zhang Y., Liu X., Sun T., Lu H., Miyazawa K., Yao L. Discoidin domain receptor 2 is associated with the increased expression of matrix metalloproteinase-13 in synovial fibroblasts of rheumatoid arthritis. Mol. Cell. Biochem. 2009, 330(1-2):141-152.
28. Kawai I., Hisaki T., Sugiura K., Naito K., Kano K. Discoidin domain receptor 2 (DDR2) regulates proliferation of endochondral cells in mice. Biochem. Biophys. Res. Commun. 2012, 427(3):611-617.
29. Xu H., Bihan D., Chang F., Huang P.H., Farndale R.W., Leitinger B. Discoidin domain receptors promote α1β1- and α2β1-integrin mediated cell adhesion to collagen by enhancing integrin activation. PLoS One 2012, 7(12):e52209.
30. Kim D., You E., Min N.Y., Lee K.H., Kim H.K., Rhee S. Discoidin domain receptor 2 regulates the adhesion of fibroblasts to 3D collagen matrices. Int. J. Mol. Med. 2013, 31(5):1113-1118.
31. Ruiz P.A., Jarai G. Discoidin domain receptors regulate the migration of primary human lung fibroblasts through collagen matrices. Fibrogenesis Tissue Repair 2012, 5(1):3.
32. Herrera-Herrera M.L., Quezada-Calvillo R. DDR2 plays a role in fibroblast migration independent of adhesion ligand and collagen activated DDR2 tyrosine kinase. Biochem. Biophys. Res. Commun. 2012, 429(1-2):39-44.
33. Zhang Yan, Jin Su., Jiangtian Yu., Xin Bu., Ren Tingting, Yao Libo An essential role of discoidin domain receptor 2 (DDR2) in osteoblast differentiation and chondrocyte maturation via modulation of Runx2 activation. J. Bone Miner. Res. 2011, 26(3):604-617.
34. Lin K.L., Chou C.H., Hsieh S.C., Hwa S.Y., Lee M.T., Wang F.F. Transcriptional upregulation of DDR2 by ATF4 facilitates osteoblastic differentiation through p38 MAPK-mediated Runx2 activation. J. Bone Miner. Res. 2010, 25(11):2489-2503.
35. Badiola I., Villacé P., Basaldua I., Olaso E. Downregulation of discoidin domain receptor 2 in A375 human melanoma cells reduces its experimental liver metastasis ability. Oncol. Rep. 2011, 26(4):971-978.
36. Beauchemin N. The colorectal tumor microenvironment: the next decade. Cancer Microenviron. 2011, 4(2):181-185.
37. Chua H.H., Yeh T.H., Wang Y.P., Huang Y.T., Sheen T.S., Lo Y.C., Chou Y.C., Tsai C.H. Upregulation of discoidin domain receptor 2 in nasopharyngeal carcinoma. Head Neck 2008, 30(4):427-436.
38. Rodrigues R., Roque L., Espadinha C., Pinto A., Domingues R., Dinis J., Catarino A., Pereira T., Leite V. Comparative genomic hybridization, BRAF, RAS, RET, and oligo-array analysis in aneuploid papillary thyroid carcinomas. Oncol. Rep. 2007, 18(4):917-926.
39. Zhang K., Corsa C.A., Ponik S.M., Prior J.L., Piwnica-Worms D., Eliceiri K.W., Keely P.J., Longmore G.D. The collagen receptor discoidin domain receptor 2 stabilizes SNAIL1 to facilitate breast cancer metastasis. Nat. Cell Biol. 2013, 15(6):677-687.
40. Ren T., Zhang J., Zhang J., Liu X., Yao L. Increased expression of discoidin domain receptor 2 (DDR2): a novel independent prognostic marker of worse outcome in breast cancer patients. Med. Oncol. 2013, 30(1):397.
41. Evtimova Vesna, Zeillinger Robert, Weidle Ulrich H. Identification of genes associated with the invasive status of human mammary carcinoma cell lines by transcriptional profiling. Tumor Biol. 2003, 24:189-198.
42. Walsh L.A., Nawshad A., Medici D. Discoidin domain receptor 2 is a critical regulator of epithelial-mesenchymal transition. Matrix Biol. 2011, 30(4):243-247.
43. Ge C., Xiao G., Jiang D., et al. Identification and functional characterization of ERK/MAPK phosphorylation sites in the Runx2 transcription factor. J. Biol. Chem. 2009, 284:32533-32543.
44. Badiola I., Olaso E., Crende O., Friedman S.L., Vidal-Vanaclocha F. Discoidin domain receptor 2 deficiency predisposes hepatic tissue to colon carcinoma metastasis. Gut 2012, 61(10):1465-1472.
45. Kuo P.L., Liao S.H., Hung J.Y., Huang M.S., Hsu Y.L. MicroRNA-33a functions as a bone metastasis suppressor in lung cancer by targeting parathyroid hormone related protein. Biochim Biophys Acta 2013, 1830(6):3756-3766.